3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 3
2
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Leukemia
23
Lymphoma
21
Leukemia, Myeloid, Acute
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
13
Multiple Myeloma
13
Breast Neoplasms
13
Ovarian Neoplasms
11
Lymphoma, Follicular
10
Lymphoma, Mantle-Cell
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Leukemia, Biphenotypic, Acute
9
Hodgkin Disease
9
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
8
Sarcoma
7
Waldenstrom Macroglobulinemia
6
Burkitt Lymphoma
6
Testicular Neoplasms
5
Testicular Germ Cell Tumor
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelomonocytic, Chronic
5
Carcinoma, Ovarian Epithelial
5
Blast Crisis
5
Myeloproliferative Disorders
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Congenital Abnormalities
4
Central Nervous System Neoplasms
4
Interventions
pegfilgrastim
1
Paclitaxel
1
Lenograstim
1
Ifosfamide
1
Gemcitabine
1
Filgrastim
1
Cisplatin
1
Beclomethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Endodermal Sinus Tumor
×
Filgrastim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled